GLP-1 receptor agonists and kidney outcomes: a meta-analysis and systematic review

Cited in blog · The Lancet Diabetes & Endocrinology, 9(9), 559-565. · 2021

Sattar N, Lee MMY, Kristensen SL, et al (2021). GLP-1 receptor agonists and kidney outcomes: a meta-analysis and systematic review. The Lancet Diabetes & Endocrinology, 9(9), 559-565.

Authors

Sattar N, Lee MMY, Kristensen SL, et al

Research lens

Sattar N, Lee MMY, Kristensen SL, et al (2021). GLP-1 receptor agonists and kidney outcomes: a meta-analysis and systematic review. The Lancet Diabetes & Endocrinology, 9(9), 559-565.

  • blog
  • novartis-pacibekitug-inflammation-2026-09-03